Existing shareholders to receive ~60% of new equity
Company: Core Scientific
The claim, verbatim
Under the Plan, shareholders as of the anticipated January 23, 2024 record date will receive new common stock and warrants constituting approximately 60% of the company's new equity, following warrant exercise and including rights offering shares.
Source (primary)
core-scientific 8-K exhibit (d598371dex992.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-14)Live source ↗
Quote: “shareholders (as of the anticipated record date of January 23, 2024) will receive shares of the Company's new common stock and warrants, constituting approximately 60% of the Company's new equity”
How we checked this
Checked on November 16, 2026. The cited source supports every part of this claim.
The release states each element: the January 23, 2024 anticipated record date, the stock and warrants, the roughly 60% share, and the warrant-exercise and rights-offering basis.
Confirmed in the source:
- Under the Plan, shareholders will receive new common stock and warrants.
- Eligibility is based on an anticipated record date of January 23, 2024.
- The shares and warrants constitute approximately 60% of the company's new equity.
- The 60% figure assumes exercise of the warrants issued to existing shareholders and includes new shares from the equity rights offering.
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312524008952/d598371dex992.htm) in full (6,640 characters, retrieved November 14, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d598371dex992.htm)
Quote: “shareholders (as of the anticipated record date of January 23, 2024) will receive shares of the Company's new common stock and warrants, constituting approximately 60% of the Company's new equity”